References

  1. Peterson K, Ukpong M. Ethical misrecognition: reframing community perspectives and debates on clinical trial conduct. 2008. Poster Abstract presentation at the XVII International AIDS conference in Mexico City. 3rd – 8th August, 2008 (Poster Presentation - MOPE1088). Google Scholar

  2. Ukpong M, Fatusi O, Peterson K. Community vs researcher’s perspectives on community demands from trials. 2008. Oral abstract presentation at the Microbicide 2008 Conference at New Delhi, India. February 24th to 27th, 2008 (Oral abstract 123). Google Scholar

  3. Ukpong MO, Peterson K. Review of the reports from the community voices in the field involved with the tenofovir controversy. Poster abstract presentation at the AIDS IMPACT conference in Gaborone, Botswana. 22nd to 24th September, 2009 (Abstract no 7.43). Google Scholar

  4. Ukpong M, Peterson K, Akanni O. Common decimals on community perspectives of the ethical conduct of clinical trials: a review of the oral tenofovir controversy. 2010. Poster discussion at the Microbicide 2010 held in Pittsburgh, USA. May 22nd to 25th, 2010. (Poster discussion 386). Google Scholar

  5. Chigwedere E, Mkunthi M, Ukpong M, Peterson K, Nthete E, Obileye O. Saying ‘no’ to clinical research: Malawi’s denial to study tenofovir (TDF) PreP. 2010. Poster presentation at the 18th IAS AIDS Conferencein Vienna, Austria. 18th to 23rd July, 2010 (Poster ThPE0249). Google Scholar

  6. Peterson K, Ukpong M. Ethical misrecognition: The early PrEP Tenofovir trial failures. 2013. Symposium presentation at the Second International HIV Social Sciences and Humanities Conference, Paris, France, July 10, 2013. Google Scholar

  7. Ukpong M, Peterson K. Oral Tenofovir Controversy II: Voices from the field: a series of reports of the oral tenofovir trials from the perspectives of active community voices engaged on the field in Cambodia, Cameroon, Nigeria, Thailand and Malawi. New HIV Vaccine and Microbicide Advocacy Society. 2009. Retrieved 19th November 2014 from: http://www.nhvmas-ng.org/publication/TDF2.pdf.

  8. World Health Organisation. Ebola Response Roadmap – situation report. 31st December, 2014. Retrieved 1st January 2015 from: http://www.who.int/csr/disease/ebola/situation-reports/en/.

  9. WHO Ebola Response Team. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. N Engl J Med. 2014; 371:1481-1495. PubMed | Google Scholar

  10. Rid A, Emmanuel E. Why Should High-Income Countries Help Combat Ebola? JAMA. doi:1001/jama.2014.12869. Google Scholar

  11. Folayan MO, Brown B. Ebola containment and the limited effectiveness of travel restrictions. Disaster Management In Press. Google Scholar

  12. Mitman G. Ebola in a stew of fear. N Engl J Med. 2014; 371(19):1763-1765. PubMed | Google Scholar

  13. Vlahos KB. Could Ebola virus become bioterrorist threat? 17th October, 2014. Retrieved 29th December, 2014 from: http://www.foxnews.com/politics/2014/10/03/could-ebola-virus-become-bioterrorist-threat/. Google Scholar

  14. World Health Organisation. Statement on the WHO Consultation on potential Ebola therapies and vaccines. Retrieved 29th November 2014 from: http://www.who.int/mediacentre/news/statements/2014/ebola-therapies-consultation/en/. Google Scholar

  15. World Health Organisation. WHO Ebola R&D Effort – vaccines, therapies, diagnostics. 18th December 2014. Retrieved 1st of January 2015 from: http://www.who.int/medicines/ebola-treatment/ebola_r_d_effort/en/. PubMed | Google Scholar

  16. UNAIDS/WHO. Ethical considerations in biomedical HIV prevention trials. 2012. Retrieved 15th January 2015 from: http://www.unaids.org/sites/default/files/media_asset/jc1399_ethical_considerations_en_0.pdf. PubMed | Google Scholar

  17. Barkin S. The challenge facing translation of basic science into clinical and community settings to improve health outcomes. Environ Health Perspect. Oct 2011; 119(10):a418–a419. PubMed | Google Scholar

  18. Miller L, Folayan MO, Allman D, Nkala B, Kasirye LM, Mingote LR, Calazans G, Mburu R, Ntombela F, Ditmore M. How ethical is your clinical trial. International Journal of Clinical Practice. 2010; 64(9):1179 – 1182. PubMed | Google Scholar

  19. Folayan MO, Mutengu-Kasirye L, Calazans G. Participating in biomedical research. Journal of the American Medical Association. 25; 302(20):2201-2202. PubMed | Google Scholar

  20. Kamuya DM, Marsh V, Kombe FK, Geissler PW, Molyneux SC. Engaging communities to strengthen research ethics in low-income settings: selection and perceptions of members of a network of representatives in coastal Kenya. 2013 Apr;13(1):10-20. Google Scholar

  21. UNAIDS/AVAC. Good participatory practice guidelines for biomedical HIV prevention trials. 2011. Retrieved 15th January 2015 from: http://www.unaids.org/sites/default/files/media_asset/JC1853_GPP_Guidelines_2011_en_0.pdf. Google Scholar

  22. Strauss RP, Sengupta S, Quinn SC, Goeppinger J, Spaulding C et al. The role of community advisory boards: involving communities in the informed consent process. Am J Public Health. 2001 Dec;91(12):1938-43. PubMed | Google Scholar

  23. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ et al. Community permission for medical research in developing countries. Clin Infect Dis. 2005 Jul 15;41(2):255-9. PubMed | Google Scholar

  24. Drayton R. The wealth of the west was built on Africa's exploitation. 20th August 2005. Retrieved 18th January 2015 from: http://www.theguardian.com/politics/2005/aug/20/past.hearafrica05. Google Scholar

  25. Maïga D, Akanmori BD, Chocarro L. Regulatory oversight of clinical trials in Africa: progress over the past 5 years. Vaccine. 2009;27(52):7249-7252. PubMed | Google Scholar

  26. Federal Ministry of Health. National code of research ethics. 2006. Available at: http://www.nhrec.net/ nhrec/National_Code_for_Health_Research_Ethics_v2.0.pdf Accessed 14 April 2014. PubMed | Google Scholar

  27. Langer A, Diaz-Olavarrieta C, Berdichevsky K, Villar J. Why is research from developing countries underrepresented in international health literature, and what can be done about it? Bull World Health Organ. 2004 Oct;82(10):802-3. PubMed | Google Scholar

  28. Rahman M, Fukui T. Biomedical publication–global profile and trend. Public Health. 2003 Jul;117(4):274-80. PubMed | Google Scholar

  29. Milsten J, Kaddar M. Managing the effects of TRIPS on the availability of priority vaccines. Bulletin of the World Health Organisation. 2006; 84(5): 360-365. PubMed | Google Scholar

  30. Intellectual Property Watch. WHO: fight Ebola now, solve patent issues later. 6th August 2014. Retrieved 15th January 2015 from: . http://www.ip-watch.org/2014/09/06/who-fight-ebola-now-solve-patent-issues-later/.

  31. Kamal-Yanni M. World AIDS Day: what does HIV teach us about access to medicine for Ebola? 28th November, 2014. Retrieved 18th January 2015 from: http://www.globalhealthcheck.org/?cat=37.

  32. Haire B, Oguntokun O. Ethics of ancillary care in low income countries: a case study of NIgeria. Afr J Reprod Health. 2014; 18(3): 135-142. PubMed | Google Scholar

  33. Haire B, Folayan MO, Fleming J. Development of guidelines for the conduct of HIV research monitoring by ethics committees in Nigeria. Afr J Reprod Health. 2014 Sep;18(3 Spec No):66-73. PubMed | Google Scholar

  34. Folayan MO, Peterson K, Haire B, Brown B, Makanjuola O, Audu K, Pelemo B, Marsh V. Debating ethical issues in HIV research: gaps between policy and practice in Nigeria. Dev World Bioeth. 2014 Jun 27. PubMed | Google Scholar

  35. Omonzejele PF. Ethical challenges posed by the Ebola virus epidemic in West Africa. J Bioeth Inq. 2014; 11(4):417-420. PubMed | Google Scholar

  36. World Health Organisation. African regulators’ meeting looking to expedite approval of vaccines and therapies for Ebola. Retrieved 23rd January 2015 from: http://www.who.int/medicines/news/AFR_reg_meet/en/.

  37. World Health Organisation. 9th annual meeting of the African Vaccine Regulatory Forum. Pretoria, 3 to 7th November, 2014. Recommendations. Retrieved 23rd January 2014 from: http://www.who.int/immunization_standards/vaccine_regulation/avaref_meeting_recommendations_14nov2014.pdf.

  38. Slotznick M. HIV project in Lao PDR wins award for South-South Cooperation. 9 December, 2011. Retrieved 23rd January 2015 from: https://www.wfp.org/stories/hiv-project-lao-pdr-wins-award-south-south-cooperation.

  39. Folayan MO, Oyedeji KS, Fatusi OA. Community members’ engagement with and involvement in genomic research: lessons to learn from the field. Developing World Bioethics. 2015 Apr;15(1):1-7. PubMed | Google Scholar

  40. Folayan MO, Adaranijo A, Durueke F, Ajuwon AJ, Adejumo AA, Ezechi O, Oyedeji K, Akanni O. Impact of three years training on capacity of ethics committees in Nigeria. Developing World Bioethics. 2014; 14(1):1-14. PubMed | Google Scholar